Company Filing History:
Years Active: 2006
Title: **Innovator Spotlight: Sara Dodd**
Introduction
Sara Dodd, an accomplished inventor based in Huntingdon, GB, has made significant contributions to pharmaceutical sciences. With a focus on innovative drug development, she has secured one patent that showcases her expertise in the field.
Latest Patents
Sara Dodd holds a patent for her work titled "Imidazopyridinones as p38 MAP Kinase Inhibitors." This invention involves a novel formulation of imidazopyridinones designed to address chronic inflammatory processes in both humans and animals. The patent outlines the specific groups R, R, R, and R as defined in claim 1, detailing the process for their preparation, associated pharmaceutical compositions, and methods for usage in treatments.
Career Highlights
Sara is currently employed at Bayer Healthcare AG, a leading firm in the healthcare sector. Her work at Bayer emphasizes her commitment to advancing medical treatments and the development of innovative pharmaceuticals.
Collaborations
Throughout her career, Sara has collaborated with notable professionals in her field, including Cristina Alonso-Alija and Martin Michels. These partnerships have enabled her to enhance her research and contribute to pioneering solutions in healthcare.
Conclusion
Sara Dodd exemplifies the spirit of innovation in the pharmaceutical industry. Her patent for imidazopyridinones not only showcases her inventiveness but also highlights her dedication to addressing chronic health issues. As she continues to work at Bayer Healthcare AG, her contributions promise to have a lasting impact on medical treatments and patient care.